ArticleCancer medicine2022

Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression.

Hua-Lin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.